Third Rock Ventures (Boston, MA)
Neil Exter joined Third Rock Ventures in 2007 and plays an integral role in the overall formation, development and business strategy of its portfolio companies. Additionally, he supports the business development efforts within the portfolio companies. He also assumes active leadership roles in its portfolio companies, functioning as interim Chief Operating Officer/Chief Business Officer through the first 12-18 months post launch.
Neil has over 17 years of business development and strategic experience, facilitating the successful development and implementation of operations and collaborations across the spectrum of newly emerging and established biotech companies.
Prior to joining Third Rock Ventures, Neil was CBO of Alantos Pharmaceuticals, leading the sale of the company to Amgen. Previously, Neil served as VP for Millennium Pharmaceuticals, directing in-licensing and M&A. Earlier in his career, Neil held various executive management roles within the high technology industry, including tenures at Hewlett Packard and Wang Laboratories.
Neil is a member of the Board of Overseers at Children's Hospital Boston and a member of the Children's Hospital Boston Board Research Committee. Additionally, Neil is a member of the Innovation Research Fund at Partners Healthcare and a member of the Advisory Council of the Electrical and Computer Engineering Department at Cornell University.
Neil holds an MBA as a Baker Scholar from Harvard Business School, a MS from Stanford University and a BS from Cornell University.